1650
S. Tu, Q. Wang, Y. Zhang, J. Xu, J. Zhang, X. Zhu, F. Shi
Vol 43
nmr (DMSO-d6): ꢀ 13.40 (s, 1H, COOH), 8.14 (s, 1H, ArH),
8.20 (dd, 1H, J1=9.6 Hz, J2=1.2 Hz, ArH), 7.85 (d, 1H, J=7.6
Hz, ArH), 7.46 (d, 1H, J=7.6 Hz, ArH), 8.14-7.45 (m, 4H, ArH),
5.10 (s, H, CH), 4.66 (s, 2H, CH2), 2.52-2.10 (m, 8H, 4CH2),
1.00 (s, 6H, 2CH3), 0.88 (s, 6H,2CH3).
2-(1,2,3,4,5,6,7,8-Octahydro-3,3,6,6-tetramethyl-1,8-dioxo-9-
phenylacridine-10(9H)-yl)acetic acid (4h).
This compound was obtained according to above general
procedure; ir (potassium bromide): 3446, 2960, 1734, 1634 cm-1;
1H nmr (DMSO-d6): ꢀ 13.29 (s, 1H, COOH), 7.20-7.01 (m, 5H,
ArH), 4.99 (s, H, CH), 4.60 (s, 2H, CH2), 2.67-2.03 (m, 8H,
4CH2), 1.01 (s, 6H, 2CH3), 0.94 (s, 6H, 2CH3).
Anal. Calcd for C25H28N2O6: C, 66.36; H, 6.24; N, 6.19;
Found C, 66.52; H, 6.08; N, 6.25.
Anal. Calcd for C25H29NO4: C, 73.68; H, 7.17; N, 3.44; Found
C, 73.82; H, 7.14; N, 3.22.
2-(9-(4-Chlorophenyl)-1,2,3,4,5,6,7,8-octahydro-3,3,6,6-tetra-
methyl-1,8-dioxoacridine-10(9H)-yl)acetic acid (4c).
This compound was obtained according to above general
procedure; ir (potassium bromide): 3421, 1643, 1602 cm-1; 1H nmr
(DMSO-d6): ꢀ 13.36 (s, 1H, COOH), 7.36 (d, 2H, J=8.0 Hz, ArH),
7.06 (d, 2H, J=8.0 Hz, ArH), 4.98 (s, H, CH), 4.62 (s, 2H, CH2),
2.80-2.05 (m, 8H, 4CH2), 1.00 (s, 6H, 2CH3), 0.89 (s, 6H, 2CH3).
Anal. Calcd for C25H28ClNO4: C, 67.94; H, 6.39; N, 3.17;
Found C, 68.09; H, 6.43; N, 3.02.
1,4-Bis(3,3,6,6-tetramethyl-10-carboxymethyl-decahydroacridine-
1, 8-dione-yl) -benzene (5a).
This compound was obtained according to above general
1
procedure; ir (potassium bromide): 3446, 1633, 1571 cm-1. H
nmr (DMSO-d6): ꢀ 13.28 (s, 2H, 2COOH), 6.94-6.77 (m, 4H,
ArH), 4.90 (s, 2H, 2CH), 4.57 (s, 4H, 2CH2), 2.67-2.00 (m, 16H,
8CH2), 0.94(s, 12H, 4CH3), 0.84 (s, 12H, 4CH3).
Anal. Calcd for C44H52N2O8: C, 71.72; H, 7.11; N, 3.80;
Found C, 71.85; H, 7.02; N, 3.64.
2-(9-(3,4-Dichlorophenyl)-1,2,3,4,5,6,7,8-octahydro-3,3,6,6-
tetramethyl-1,8-dioxoacridine-10(9H)-yl)acetic acid (4d).
This compound was obtained according to above general
1
1,3-bis(3,3,6,6-Tetramethyl-10-carboxymethyl-decahydroacridine-
1, 8-dione-yl)- benzene (5b).
procedure; ir (potassium bromide): 3421, 1662, 1619 cm-1; H
nmr (DMSO-d6): ꢀ 13.35 (s, 1H, COOH), 7.31(d, 1H, J= 8.4 Hz,
ArH), 7.29 (s, 1H, ArH), 7.12(d, 1H, J= 8.0 Hz, ArH), 5.16 (s,
H, CH), 4.64 (s, 2H, CH2), 2.57-1.98 (m, 8H, 4CH2),1.01 (s, 6H,
2CH3), 0.86 (s, 6H, 2CH3).
Anal. Calcd for C25H27Cl2NO4: C, 63.03; H, 5.71; N, 2.94;
Found C, 63.15; H, 5.68; N, 3.11.
This compound was obtained according to above general
1
procedure; ir (potassium bromide): 3446, 1660, 1626 cm-1; H
nmr (DMSO-d6): ꢀ 13.30 (s, 2H, 2COOH), 7.08-6.94 (m, 4H,
ArH), 4.97 (s, 2H, 2CH), 4.48 (s, 4H, 2CH2), 2.59-2.00 (m, 16H,
8CH2), 1.04 (s, 12H, 4CH3), 0.89 (s, 12H, 4CH3).
Anal. Calcd for C44H52N2O8: C, 71.72; H, 7.11; N, 3.80;
Found C, 71.89; H, 7.23; N, 3.63.
2-(9-(2,4-Chlorophenyl)-1,2,3,4,5,6,7,8-octahydro-3,3,6,6-tetra-
methyl-1,8-dioxoacridine-10(9H)-yl)acetic acid (4e).
9-(4-Chlorophenyl)-3,3,6,6-tetramethyl-3,4,5,6,7,9-hexahydro-
(1H)-xanthene-1,8(2H)-dione (6).
This compound was obtained according to above general
1
procedure; ir (potassium bromide): 3500, 1623, 1570 cm-1; H
This compound was obtained according to above general
procedure; ir (potassium bromide): 2980, 1680, 1660, 1620 cm-1;
1H nmr (CDCl3): ꢀ 7.26 (s, 4H, ArH), 4.64 (s, 1H, CH), 4.48 (s,
4H, 2CH2), 2.14-2.03 (m, 8H, 4CH2), 1.10 (s, 6H, 2CH3), 0.98
(s, 6H, 2CH3).
nmr (DMSO-d6): ꢀ 13.35 (s, 1H, COOH), 7.24(d, 1H, J= 8.4 Hz,
ArH), 7.20 (s, 1H, ArH), 7.10 (d, 1H, J= 8.0 Hz, ArH), 5.16 (s,
H, CH), 4.65 (s, 2H, CH2), 2.52-2.02 (m, 8H, 4CH2), 1.00 (s,
6H, 2CH3), 0.86 (s, 6H, 2CH3).
Anal. Calcd for C25H27Cl2NO4: C, 63.03; H, 5.71; N, 2.94;
Found C, 63.21; H, 5.56; N, 2.73.
Anal. Calcd for C23H25ClO3: C, 71.77; H, 6.54; Found C,
71.92; H, 6.32.
2-(1,2,3,4,5,6,7,8-Octahydro-9-(3,4-dimethoxyphenyl)-3,3,6,6-
tetramethyl-1,8-dioxoacridine-10(9H)-yl)acetic acid (4f).
2,2'-(4-Chlorophenyl)methylenebis(3-hydroxy-5,5-dimethyl-2-
cyclohexen-1-one(7).
This compound was obtained according to above general
1
procedure; ir (potassium bromide): 3303, 1655, 1620 cm-1; H
White acerose solid, m.p. 135-136°C (lit. [11] 134-135°C).
[(5,5-Dimethyl-3-oxocyclohex-1-en-1-yl)amino]acetic acid (8).
This compound was obtained according to above general
nmr (DMSO-d6): ꢀ 13.30 (s, 1H, COOH), 6.81(s, 1H, ArH), 6.76
(d, 1H, J= 8.4 Hz, ArH), 6.72 (d, 1H, J= 8.0 Hz, ArH), 4.95 (s,
H, CH), 4.61 (s, 2H, CH2), 3.66 (s, 3H,OCH3), 3.64 (s, 3H,
OCH3) 2.62-2.04 (m, 8H, 4CH2), 1.04 (s, 6H, 2CH3), 0.89 (s,
6H, 2CH3).
1
procedure; ir (potassium bromide): 3336, 2961,1716 cm-1; H
nmr (DMSO-d6): ꢀ 12.79 (s, 1H, COOH), 7.15 (s, 1H, NH), 4.68
(s, ꢀH, CH), 3.76 (d, 2H, J=6.0 Hz CH2), 2.23 (s, 2H, CH2),
1.97 (s, 2H, CH2), 0.98 (s, 6H, 2CH3).
Anal. Calcd for C27H33NO6: C, 69.36; H, 7.11; N, 3.00;
Found: C, 69.58; H, 7.02; N, 2.86.
Anal. Calcd for C10H15NO3: C, 60.90; H, 7.67; N, 7.10; Found
C, 61.02; H, 7.64; N, 7.08.
2-(1,2,3,4,5,6,7,8-Octahydro-9-(4-hdroxy-3-methoxyphenyl)-
3,3,6,6-tetramethyl-1,8-dioxoacridine-10(9H)-yl)acetic acid (4g).
This compound was obtained according to above general
procedure; ir (potassium bromide): 3480, 1632, 1593 cm-1; 1H nmr
(DMSO-d6): ꢀ 13.31 (s, 1H, COOH), 8.55 (s, 1H, OH), 6.76 (s, 1H,
ArH), 6.60 (d, 1H, J=8.0 Hz, ArH), 6.52 (d, 1H, J=8.0 Hz, ArH),
4.91 (s, H, CH), 4.43 (s, 2H, CH2), 3.66 (s, 3H, OCH3), 2.59-2.04
(m, 8H, 4CH2), 1.08 (s, 6H, 2CH3), 1.06 (s, 6H, 2CH3).
REFERENCES AND NOTES
[1] B. Wysocka-Skrzela and A. Ledochowski, Roccz. Chem., 50,
127 (1976); A. Nasim and T. Brychey, Muta. Res., 65, 261 (1979); U.
Thull and B. Testa, Biochem. Pharmacol, 447, 2307 (1994); E. Reil, M.
Scoll, K. Masson and W. Oettmeier, Biochem. Soc. Trans., 22, 62
(1994); Y. Mandi, K. Regely, I. Ocsovszky, J. Barbe and J. P. Galy,
Molnar, J. Anticaner Res., 14, 2633 (1994).
Anal. Calcd for C26H31NO6: C, 68.86; H, 6.89; N, 3.09; Found
C, 69.01; H, 6.78; N, 2.89.